Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
6.37
-0.40 (-5.91%)
At close: Sep 11, 2025, 3:59 PM
Cyclacel Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Net Income | -11.21M | -22.55M | -21.2M | -18.89M |
Depreciation & Amortization | 6K | 31K | 32K | 43K |
Stock-Based Compensation | 592K | 1.47M | 1.51M | 1.16M |
Other Working Capital | 4.47M | 4.71M | -3.74M | -3.76M |
Other Non-Cash Items | -37K | -69K | -967K | -1.49M |
Deferred Income Tax | n/a | n/a | 967K | 1.49M |
Change in Working Capital | 2.66M | 5.01M | -1.17M | -853K |
Operating Cash Flow | -7.99M | -16.11M | -20.83M | -18.54M |
Capital Expenditures | n/a | -6K | -7K | -27K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -6K | -7K | -27K |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -201K | -201K | -201K |
Other Financial Acitivies | 1.61M | n/a | n/a | 4.57M |
Financial Cash Flow | 7.82M | 848K | 3M | 21.74M |
Net Cash Flow | -241K | -14.97M | -18.21M | 3.15M |
Free Cash Flow | -7.99M | -16.12M | -20.83M | -18.57M |